Guardian Pharmacy Services, Inc.
GRDN
$31.54
$0.391.25%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.68% | 18.53% | 19.54% | 17.42% | 16.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.68% | 18.53% | 19.54% | 17.42% | 16.86% |
| Cost of Revenue | 18.77% | 18.97% | 19.55% | 17.44% | 17.45% |
| Gross Profit | 18.32% | 16.72% | 19.52% | 17.31% | 14.49% |
| SG&A Expenses | -22.66% | 94.54% | 112.36% | 107.80% | 66.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.55% | 30.55% | 32.84% | 30.69% | 25.74% |
| Operating Income | 280.19% | -189.60% | -175.76% | -184.90% | -188.94% |
| Income Before Tax | 185.92% | -308.89% | -258.83% | -276.24% | -276.71% |
| Income Tax Expenses | 10,701.70% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 157.87% | -348.72% | -281.93% | -288.32% | -277.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 103.73% | 61.25% | 16.63% | -17.63% | -26.16% |
| Net Income | 146.14% | -681.55% | -450.66% | -465.19% | -469.83% |
| EBIT | 280.19% | -189.60% | -175.76% | -184.90% | -188.94% |
| EBITDA | 602.43% | -142.27% | -136.26% | -142.24% | -129.64% |
| EPS Basic | 139.95% | -716.46% | -- | -- | -- |
| Normalized Basic EPS | 161.66% | -887.37% | -- | -- | -- |
| EPS Diluted | 139.46% | -718.60% | -- | -- | -- |
| Normalized Diluted EPS | 160.70% | -895.41% | -- | -- | -- |
| Average Basic Shares Outstanding | 103.01% | 304.42% | -- | -- | -- |
| Average Diluted Shares Outstanding | 106.30% | 308.85% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -1.05% | -1.21% | -1.26% | -1.40% |